Geode Capital Management
TLSI icon

Geode Capital Management’s TriSalus Life Sciences TLSI Stock Holding History

Geode Capital Management’s Portfolio TLSI Stock Details TLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.42M Buy
1,190,067
+412,973
+53% +$1.64M ﹤0.01% 2869
2026
Q1 		$3.11M Buy
777,094
+25,887
+3% +$127K ﹤0.01% 2955
2025
Q4 		$5.25M Buy
751,207
+196,752
+35% +$1.1M ﹤0.01% 2743
2025
Q3 		$2.58M Buy
554,455
+99,404
+22% +$465K ﹤0.01% 3099
2025
Q2 		$2.48M Buy
455,051
+235,627
+107% +$1.26M ﹤0.01% 3069
2025
Q1 		$1.21M Buy
219,424
+15,287
+7% +$81.4K ﹤0.01% 3239
2024
Q4 		$1.02M Buy
204,137
+3,710
+2% +$15.7K ﹤0.01% 3371
2024
Q3 		$924K Buy
200,427
+62,542
+45% +$331K ﹤0.01% 3382
2024
Q2 		$761K Buy
137,885
+3,786
+3% +$32.1K ﹤0.01% 3411
2024
Q1 		$1.31M Buy
134,099
+8,337
+7% +$77K ﹤0.01% 3260
2023
Q4 		$1.06M Buy
125,762
+108,523
+630% +$559K ﹤0.01% 3337
2023
Q3 		$88.3K Hold
17,239
– – ﹤0.01% 4288
2023
Q2 		$181K Hold
17,239
– – ﹤0.01% 4087
2023
Q1 		$176K Hold
17,239
– – ﹤0.01% 4115
2022
Q4 		$173K Hold
17,239
– – ﹤0.01% 4175
2022
Q3 		$171K Hold
17,239
– – ﹤0.01% 4298
2022
Q2 		$169K Hold
17,239
– – ﹤0.01% 4369
2022
Q1 		$168K Sell
17,239
-1,367
-7% -$13.5K ﹤0.01% 4458
2021
Q4 		$183K Hold
18,606
– – ﹤0.01% 4516
2021
Q3 		$184K Hold
18,606
– – ﹤0.01% 4484
2021
Q2 		$181K Buy
18,606
+1,341
+8% +$13.1K ﹤0.01% 4376
2021
Q1 		$166K Buy
+17,265
New +$175K ﹤0.01% 4172

Other funds holding TLSI

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Cerity Partners
Cerity Partners New York $82.7B AUM 28.53% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
WPC
White Pine Capital Bloomington, Minnesota $423M AUM 67.01% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return

Geode Capital Management's TLSI Position: Q2 2026 in Review

Geode Capital Management increased its TriSalus Life Sciences (TLSI) stake by 53% in Q2 2026, buying an estimated $1.64M and bringing the position to 1,190,067 shares worth $5.42M. The position accounts for ﹤0.01% of the portfolio, ranked #2869.

Geode Capital Management first reported a position in TLSI in Q1 2021 and has held it in 22 quarters since. 79 funds tracked by Wall St. Rank hold TLSI as of Q2 2026.

  • Geode Capital Management held 1,190,067 shares of TriSalus Life Sciences worth $5.42M as of Q2 2026.
  • Geode Capital Management bought 412,973 TriSalus Life Sciences shares in Q2 2026, an estimated $1.64M.
  • TriSalus Life Sciences made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #2869 holding.
  • Geode Capital Management first reported a position in TriSalus Life Sciences in Q1 2021 and has held it in 22 quarters since.
  • 79 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.